MedTrace Logo

Personalized Medicine Decision-Making in a Virtual Clinical Setting

NCT02108041 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 196

Last updated 2026-05-07

No results posted yet for this study

Summary

Background:

-How people respond to drugs depends in part on their genes. For some drugs, doctors can use an individuals genetic background to help in dosing the drug. Researchers want to know how doctors incorporate personalized or genomic medicine into clinical practice.

Objective:

-To study how physicians make personalized treatment decisions

Eligibility:

-Healthy adult primary care physicians who are internal (or family) medicine residents.

Design:

* Participants will complete a screening form.
* Participants will put on a headset, called a head-mounted display, showing a virtual reality environment.
* The environment will contain an exam room and the virtual patient.
* After interacting with the virtual patient, participants will complete a series of survey measures.
* Participation will last for about 60 minutes. The virtual patient interaction and follow-up questions will be audio taped.

Conditions

Sponsors & Collaborators

  • National Human Genome Research Institute (NHGRI)

    lead NIH

Principal Investigators

  • Susan J Persky, Ph.D. · National Human Genome Research Institute (NHGRI)

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Primary Completion
2020-10-08
Completion
2020-10-08

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02108041 on ClinicalTrials.gov